Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Candi Antibody is a biotechnology company based in the Shunde district of Foshan, China, specializing in the development and production of high-quality antibodies for research and diagnostic applications. The company leverages advanced platforms such as phage display and hybridoma technology to provide custom antibody discovery services, including monoclonal and polyclonal antibody generation. Their product portfolio includes primary and secondary antibodies, as well as specialized reagents for ELISA, Western Blot, and immunohistochemistry. Candi Antibody serves academic institutions, pharmaceutical companies, and diagnostic laboratories globally, providing technical support and customized solutions for complex protein detection. The firm is positioned as a key service provider within the Guangdong-Hong Kong-Macao Greater Bay Area's growing life sciences ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Schunde Kangdi Antibody Biotech.